Remove keyword elizabeth-holmes
article thumbnail

The enduring value of digital transformation

Star OUTiCO

Chief Technology Transformation Officer at Novartis, Elizabeth Theophille, saw 2021 as a year of solidification of the mass movement to digital systems, including within drug discovery and development, manufacturing, and patient treatment. Elizabeth Theophille, Chief Technology Transformation Officer, Novartis. Insight + Advancement.

Pharma 52